GlassScriptPhysician profile
Leah A Reitzi
NPI 1245777192
$17,818.95
in general payments reported to CMS, 2019-2025
44 companies · $1,715 in 2025
The $1,715 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $745 · 2022: $7,351 · 2023: $5,501 · 2024: $2,507 · 2025: $1,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,181 · Long Term Medical Supply Or Device Loan: $3,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,181.00 |
| Long Term Medical Supply Or Device Loan | $3,541.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $8,230.16 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $1,404.08 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $829.65 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $729.42 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $673.19 | 2021-2024 | Xarelto |
| Tactile Systems Technology INC | $654.36 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Amgen INC. | $575.03 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $440.26 | 2021-2025 | Camzyos, Eliquis |
| Pfizer INC. | $414.72 | 2021-2025 | |
| Esperion Therapeutics, INC. | $397.40 | 2021-2025 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $379.97 | 2021-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $338.09 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Novo Nordisk INC | $335.94 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Lexicon Pharmaceuticals, INC. | $239.93 | 2023-2024 | Inpefa |
| Abbott Laboratories | $234.24 | 2023-2025 | Jeti Peripheral Catheter, Jot Dx, Navitor |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $201.88 | 2022-2025 | Injectafer |
| Cardiovascular Systems INC. | $198.53 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $191.96 | 2023-2024 | Lifevest |
| Amarin Pharma, INC. | $169.51 | 2021-2022 | |
| Medtronic, INC. | $167.11 | 2022-2024 | Symplicity G3, Onyx Frontier, Ffrangio |
| Boston Scientific Corporation | $115.24 | 2022-2024 | Varithena Administration Pack, Patientcare Link, Watchman Flx |
| Kiniksa Pharmaceuticals International, Plc | $112.36 | 2024 | Arcalyst |
| Biotronik INC. | $85.51 | 2022-2025 | Biomonitor, Acticor 7 Vr-T Dx |
| Chiesi USA, INC. | $60.80 | 2025 | Kengreal, Juxtapid |
| Bardy Diagnostics, INC. | $60.00 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $58.60 | 2021-2022 | |
| Lilly USA, LLC | $57.83 | 2024-2025 | Zepbound, Mounjaro |
| Inspire Medical Systems, INC. | $51.51 | 2025 | Inspire |
| Cashflow Solutions, LLC | $48.02 | 2024-2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Impulse Dynamics (USA) INC. | $38.65 | 2023 | Optimizer |
| Bridgebio Pharma, INC. | $33.84 | 2025 | Attruby |
| Abbvie INC. | $30.16 | 2025 | |
| Baxter Healthcare | $28.78 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Bard Peripheral Vascular, INC. | $28.24 | 2022 | |
| Heartflow, INC. | $25.63 | 2025 | |
| Medicomp INC | $23.32 | 2024 | Telepatch Cardiac Monitor |
| Shockwave Medical, INC | $22.09 | 2022 | |
| Ucb, INC. | $21.94 | 2025 | Bimzelx |
| Scpharmaceuticals INC. | $20.97 | 2025 | |
| Kestra Medical Technology Services, INC. | $20.85 | 2023 | Assure Wcd |
| Galderma Laboratories, L.P. | $18.71 | 2025 | Nemluvio |
| Terumo Medical Corporation | $17.20 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.66 | 2025 | |
| Sun Pharmaceutical Industries INC. | $16.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Reitzi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.